行情

ABBV

ABBV

艾伯维
NYSE

实时行情|Nasdaq Last Sale

134.04
-1.17
-0.86%
交易中 15:17 01/20 EST
开盘
134.49
昨收
135.21
最高
134.80
最低
133.04
成交量
333.45万
成交额
--
52周最高
138.15
52周最低
101.81
市值
2,369.71亿
市盈率(TTM)
31.91
分时
5日
1月
3月
1年
5年
$1000 Invested In This Stock 5 Years Ago, Would Be Worth This Much
AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 2.43% on an annualized basis.
Benzinga · 1小时前
Kinloch Capital, LLC Buys Vanguard Consumer Discretionary ETF, Clorox Co, JPMorgan Ultra-Short ...
Investment company Kinloch Capital, LLC (Current Portfolio) buys Vanguard Consumer Discretionary ETF, Clorox Co, JPMorgan Ultra-Short Income ETF, AbbVie Inc, Cardinal Health Inc, sells Vanguard Health Care ETF, AT&T Inc, Nucor Corp, Target Corp during the ...
GuruFocus.com · 1小时前
Evolus on the rise after Truist upgraded on prospects for wrinkles treatment
Evolus (EOLS +10.2%) has recorded the biggest intraday gain in more than three months after Truist upgraded the Pharma company to Buy from Hold, citing its performance in the Jeuveau
Seekingalpha · 2小时前
Vertex upgraded to outperform at BMO on bullish outlook for rare kidney disease candidate
BMO has upgraded shares of Vertex Pharmaceuticals (VRTX +1.3%) based on recent promising data for VX-147, its candidate for the rare kidney condition focal segmental glomerulosclerosis ("FSGS"). In December, Vertex
Seekingalpha · 2小时前
10 Best Dividend Stocks According to Thomas Steyer’s Farallon Capital
In this article, we discuss the 10 best dividend stocks according to Thomas Steyer’s Farallon Capital. You can skip our detailed analysis of the hedge fund and its recent developments, and go directly to read 5 Best Dividend Stocks According to Thomas Stey...
Insider Monkey · 3小时前
10 Best Dividend Stocks to Buy According to Cliff Asness’ AQR Capital Management
In this article, we discuss the 10 best dividend stocks to buy according to Cliff Asness’ AQR Capital Management. You can skip our detailed analysis of the hedge fund and its recent developments, and go directly to read 5 Best Dividend Stocks to Buy Accord...
Insider Monkey · 5小时前
Barclays Adjusts AbbVie's Price Target to $133 from $118, Keeps Equalweight Rating
MT Newswires · 7小时前
Strategic Capital Advisers, Inc. 收购 Archer-Daniels Midland Co、AbbVie Inc、SPDR S&P ...
Investment company Strategic Capital Advisers, Inc. (Current Portfolio) buys Archer-Daniels Midland Co, AbbVie Inc, SPDR S&P Global Natural Resources ETF, Exelon Corp, Invesco Water Resources ETF, sells Lockheed Martin Corp, Kimberly-Clark Corp, Invesco S&...
GuruFocus.com · 21小时前
更多
财务预测
实际值（美元）
预测值（美元）
利润表更多
净利润（美元）
同比（%）
资产负债表更多
总资产（美元）
总负债（美元）
资产负债率（%）
现金流表更多
经营现金流（美元）
同比（%）
了解ABBV最新的财务预测，通过ABBV每股收益，每股净资产，每股现金流等数据分析艾伯维近期的经营情况，然后做出明智的投资选择。
分析师评级

26位分析师的综合评级

买入

免责声明：分析师观点仅供投资者决策参考，不构成任何买卖投资建议。

19.23%强力推荐
61.54%买入
19.23%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测ABBV价格均价为138.26，最高价位172.00，最低价为105.00。
最高172.00
均价138.26
最低105.00
现价134.04
EPS
实际EPS
预期EPS
0.831.672.503.33
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
机构持股
总机构数: 3,356
机构持股: 12.73亿
持股比例: 72.01%
总股本: 17.68亿
类型机构数股数
增持
1,302
5,342.83万
建仓
104
333.44万
减持
863
5,591.42万
平仓
94
496.25万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
制药
+0.01%
制药与医学研究
+0.15%
高管信息
Chairman/Chief Executive Officer/Director
Richard Gonzalez
President/Vice Chairman - Management
Michael Severino
Vice Chairman/Chief Financial Officer/Director
Robert Michael
Vice Chairman - Management
Laura Schumacher
Chief Human Resource Officer/Executive Vice President
Timothy Richmond
Executive Vice President
Henry Gosebruch
Executive Vice President
Azita Saleki - Gerhardt
Senior Vice President
Thomas Hudson
Senior Vice President
Elaine Sorg
Senior Vice President
Jeffrey Stewart
Senior Vice President
Carrie Strom
Vice President/Controller
Brian Durkin
Lead Director/Independent Director
Glenn Tilton
Independent Director
Robert Alpern
Independent Director
Roxanne Austin
Independent Director
William Burnside
Independent Director
Thomas Freyman
Independent Director
Brett Hart
Independent Director
Edward Liddy
Independent Director
Melody Meyer
Independent Director
Edward Rapp
Independent Director
Rebecca Roberts
Independent Director
Frederick Waddell
公告日期
每股分红
除权日期
--
每股分红:USD 1.41
2022/01/13
--
每股分红:USD 1.3
2021/10/14
2021/06/17
每股分红:USD 1.3
2021/07/14
2021/02/18
每股分红:USD 1.3
2021/04/14
2020/10/30
每股分红:USD 1.3
2021/01/14
2020/09/11
每股分红:USD 1.18
2020/10/14
2020/06/17
每股分红:USD 1.18
2020/07/14
2020/02/20
每股分红:USD 1.18
2020/04/14
2019/11/01
每股分红:USD 1.18
2020/01/14
2019/09/06
每股分红:USD 1.07
2019/10/11
2019/06/20
每股分红:USD 1.07
2019/07/12
2019/02/21
每股分红:USD 1.07
2019/04/12
2018/11/02
每股分红:USD 1.07
2019/01/14
2018/09/07
每股分红:USD 0.96
2018/10/12
2018/06/14
每股分红:USD 0.96
2018/07/12
2018/02/15
每股分红:USD 0.96
2018/04/12
2017/10/26
每股分红:USD 0.71
2018/01/11
2017/09/08
每股分红:USD 0.64
2017/10/12
2017/06/23
每股分红:USD 0.64
2017/07/12
2017/02/17
每股分红:USD 0.64
2017/04/11
  • 全部
  • 财务报告
  • 内部人交易
更多
ABBV 简况
AbbVie Inc (AbbVie) 是一家以研究为基础的生物制药公司。该公司从事药物和疗法的研发、制造、商业化和销售。AbbVie提供各种治疗类别的产品，包括免疫学产品，其中包括Humira、Skyrizi和Rinvoq；肿瘤产品包括Imbruvica和Venclexta；美学产品包括Botox Cosmetic、Juvederm Collection等美学产品；神经科学产品，例如Botox Therapeutic、Vraylar、Duopa和Duodopa以及Ubrelvy；眼部护理产品包括Lumigan、Alphagan和Restasis；女性保健品包括Lo Loestrin、Orilissa等女性保健品；其他主要产品，包括Mavyret、Creon、Lupron、Linzess和Synthroid。该公司的产品通过AbbVie拥有的配送中心和公共仓库直接销往全球的批发商、分销商、政府机构、医疗保健机构和独立零售商。

微牛提供AbbVie Inc(NYSE-ABBV)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的ABBV股票新闻，以帮助您做出投资决策。

模拟交易：模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易ABBV股票基本功能。